{
  "ptid_time": "073_S_4311_2011-10-17",
  "img_path": "/data/qiuhui/data/adni/images/073_S_4311/2011-10-17/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 31,490 mm³, 12.2% above the reference mean. With a Z-score of 0.28 (61.0th percentile), this represents normal volume ; hippocampal volume measures 5,497 mm³, 22.7% below the reference mean. With a Z-score of -2.09 (1.9th percentile), this represents significant atrophy; whole brain volume measures 1,057,600 mm³, 8.5% above the reference mean. With a Z-score of 1.07 (85.8th percentile), this represents mild enlargement; entorhinal cortex volume measures 2,951 mm³, 19.7% below the reference mean. With a Z-score of -1.21 (11.4th percentile), this represents mild atrophy; fusiform gyrus volume measures 18,108 mm³, 6.4% above the reference mean. With a Z-score of 0.59 (72.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,088 mm³, 5.6% below the reference mean. With a Z-score of -0.49 (31.2th percentile), this represents normal volume . ",
  "text_data": "Age is 72.5 years. Gender is Female. Education: 18 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Respiratory; Musculoskeletal; Renal-Genitourinary; Major Surgical Procedures. MMSE: 28.0. MoCA: 21.0. Logical Memory: 8.0. Laboratory findings: Neutrophils: 44.00 (significant reduced); Lymphocytes: 45.70 (significant elevated); Lymphocytes: 2.84 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.14 SUVR (normal ); Amyloid beta: 1244.00 pg/mL (normal ); Total tau: 314.20 pg/mL (normal ); Phosphorylated tau: 27.56 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume shows significant atrophy (Z-score -2.09, 1.9th percentile), and the entorhinal cortex has mild atrophy (Z-score -1.21, 11.4th percentile), both of which are key regions affected in Alzheimer's disease. However, cognitive testing shows a normal MMSE (28/30) but borderline MoCA (21/30), with normal CSF biomarkers (Aβ, T-tau, P-tau) and amyloid PET (AV45).  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to structural atrophy in memory-related regions but normal biomarkers and near-normal MMSE)",
  "timestamp": "2025-07-26T09:42:37.251381"
}